Shunsuke Matsunaga and MIZUHO MEDY Co.,Ltd. agreed to acquire 33.1% stake in Bio Matrix Research, Inc. from JCR Pharmaceuticals Co., Ltd. (TSE:4552) on September 25, 2014. Under the terms of the transaction, Shunsuke Matsunaga will acquire 5,000 shares and MIZUHO MEDY will acquire 1,500 shares. Post transaction, JCR Pharmaceuticals will hold 1,213 shares of Bio Matrix Research.

The Board of JCR Pharmaceuticals resolved the transaction. The transaction is expected to close on October 31, 2014. The transaction is expected to have negligible effect on JCR Pharmaceuticals' financial results.